Hospital Pharmacist & Clinical Pharmcologist
Dr. D.J.A.R. (Dirk Jan) Moes
Area(s) of expertise:
Clinical Pharmacology, Pharmacometry, PK-PD Modelling, Transplantation, Oncology
Clinical Pharmacology, Pharmacometry, PK-PD Modelling, Transplantation, Oncology
&w=400&h=400)
Introduction
In 2009 I started my PhD trajectory that focused on optimizing therapy everolimus in kidney transplant patients. From 2011 I combined that position with the specialization to become a hospital pharmacist. I have been working in my current position since 2017.
Scientific research
My interest is in optimizing pharmacotherapy using pharmacometrics (PK/PD Modeling. During my PhD, I used this to optimize immunosuppressive therapy in kidney transplantation. Since 2015 I have continued and expanded this work.
Grants:
Main applicant:
2023: ATG Optimization (Janivo)
2019: Iohexol study (Sandoz Pharma)
2016: ENVAR study (Chiesi Pharma)
Co-applicant:
2024: Cabozantinib SKIPPY (Treadmeds)
2021: Enzaadapt study (Cancer Fund)
2021: Implementing TRAX Box (Sandoz Pharma)
2020: Liver transplant home monitoring project (Sandoz Pharma)
2018: KWF implementation project 11575
2014: RRFD study (Astellas Pharma)
Grants:
Main applicant:
2023: ATG Optimization (Janivo)
2019: Iohexol study (Sandoz Pharma)
2016: ENVAR study (Chiesi Pharma)
Co-applicant:
2024: Cabozantinib SKIPPY (Treadmeds)
2021: Enzaadapt study (Cancer Fund)
2021: Implementing TRAX Box (Sandoz Pharma)
2020: Liver transplant home monitoring project (Sandoz Pharma)
2018: KWF implementation project 11575
2014: RRFD study (Astellas Pharma)
